US equities
|
NVDA
$151.78
▼-2.37%
MU
$701.78
▼-1.49%
AMD
$513.97
▲+2.10%
SPCX
$144.33
▲+1.86%
SNDK
$777.00
▼-2.54%
TSLA
$384.10
▲+1.05%
AAPL
$353.62
▲+0.49%
AMZN
$265.93
▲+3.12%
NVDA
$151.78
▼-2.37%
MU
$701.78
▼-1.49%
AMD
$513.97
▲+2.10%
SPCX
$144.33
▲+1.86%
SNDK
$777.00
▼-2.54%
TSLA
$384.10
▲+1.05%
AAPL
$353.62
▲+0.49%
AMZN
$265.93
▲+3.12%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
GRI Bio, Inc. - Common Stock
(NQ:
GRI
)
1.280
-0.070 (-5.21%)
Delayed Quote
Updated: 12:40 PM EST, Nov 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about GRI Bio, Inc. - Common Stock
Nika Pharmaceuticals (OTCQB: NIKA) Targets Immune Health Breakthroughs Across HIV, Cancer, and Chronic Diseases
December 30, 2025
Via
AB Newswire
Topics
Intellectual Property
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
July 22, 2025
Via
ACCESS Newswire
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
June 12, 2024
From
Connect Biopharma Holdings Limited
Via
GlobeNewswire
JTC Team Announces the Launch of the Virtual Investor "What This Means" On Demand Video Series
August 16, 2023
Via
ACCESSWIRE
JTC Team to Host Two Virtual Investor Spotlight Events on Thursday, July 27th
July 26, 2023
Via
ACCESSWIRE
September Is Pulmonary Fibrosis Awareness Month: Here’s What One Company Is Doing To Develop A Treatment For This Deadly Disease
September 29, 2023
Via
ACCESSWIRE
GRI Bio Engages B2i Digital to Deploy Cutting-Edge Engagement Campaign
August 29, 2023
La Jolla, California--(Newsfile Corp. - August 29, 2023) - GRI Bio, Inc. (NASDAQ: GRI),...
Via
Newsfile
GRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupus
August 25, 2023
Via
ACCESSWIRE